[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 3162 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  1st Session
                                S. 3162

To require the Secretary of Defense to carry out a pilot program under 
    which the Secretary shall develop and implement a comprehensive 
    wastewater surveillance system at certain installations of the 
             Department of Defense, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            November 7, 2025

  Ms. Slotkin introduced the following bill; which was read twice and 
              referred to the Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
To require the Secretary of Defense to carry out a pilot program under 
    which the Secretary shall develop and implement a comprehensive 
    wastewater surveillance system at certain installations of the 
             Department of Defense, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PILOT PROGRAM ON WASTEWATER SURVEILLANCE SYSTEM OF 
              DEPARTMENT OF DEFENSE.

    (a) Pilot Program Required.--Commencing not later than 180 days 
after the date of the enactment of this Act, the Secretary of Defense 
shall carry out a pilot program under which the Secretary shall develop 
and implement a comprehensive wastewater surveillance system at not 
fewer than four installations of a military department at which the 
Secretary seeks to improve the testing, identification, and analysis of 
usage of covered drugs and to identify the prevalence of infectious 
diseases among members of the Armed Forces at the installation (in this 
section referred to as the ``pilot program'').
    (b) Technologies and Data System Used.--In carrying out the pilot 
program, the Secretary shall ensure the system developed and 
implemented under subsection (a) is comprised of appropriate 
technologies and a uniform data system across the Department of 
Defense.
    (c) Minimum Requirements.--In carrying out the pilot program, the 
Secretary shall establish, at a minimum--
            (1) at least one wastewater surveillance system for 
        monitoring of use of covered drugs at one installation; and
            (2) at least one wastewater surveillance system for 
        monitoring of infectious diseases at one installation.
    (d) Duration.--The pilot program shall be carried out during a two-
year period beginning on the date of the commencement of the pilot 
program.
    (e) Report.--Not later than 90 days after the termination of the 
pilot program, the Secretary shall submit to the congressional defense 
committees a report that includes the following:
            (1) A summary of the findings from the wastewater 
        surveillance system under the pilot program.
            (2) Recommendations for interventions or policy changes 
        based on trends observed under the pilot program.
            (3) An assessment of the effectiveness of the pilot program 
        in enhancing force health protection and readiness.
    (f) Use of Existing Resources and Authorities.--The Secretary shall 
use existing resources and authorities of the Department of Defense, as 
the Secretary determines appropriate, to implement the pilot program.
    (g) Definitions.--In this section:
            (1) Congressional defense committees.--The term 
        ``congressional defense committees'' has the meaning given that 
        term in section 101(a)(16) of title 10, United States Code.
            (2) Covered drug defined.--The term ``covered drug''--
                    (A) except as provided in subparagraph (B), means a 
                drug included on schedule I or schedule II established 
                under section 202 of the Controlled Substances Act (21 
                U.S.C. 812); and
                    (B) does not include a drug that--
                            (i) was newly included on such schedule I 
                        or schedule II;
                            (ii) was previously approved under section 
                        505 of the Federal Food, Drug, and Cosmetic Act 
                        (21 U.S.C. 355); and
                            (iii) received such approval not later than 
                        20 years before the date of the enactment of 
                        this Act.
                                 <all>